Achieve Life Sciences Overview
Achieve Life Sciences (ACHV) has a P/E ratio of -4.67, below the Technology sector average of 27.6.
Get informed when a big investor buys or sells
+ Follow-4.67
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Achieve Life Sciences's p/e ratio stands at -4.67. That is below the Technology sector average of 27.6. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Achieve Life Sciences sits lower the Technology benchmark (27.6) with a P/E ratio of -4.67. That is roughly 116.9% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether -4.67 is attractive depends on Achieve Life Sciences's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Achieve Life Sciences's P/E ratio evolved across reporting periods, while the comparison chart places ACHV next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Technology, P/E ratio is commonly used to spot outliers. Achieve Life Sciences's reading of -4.67 (sector avg 27.6) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
